In endometrial cancer, FGFR2 has been reported to be activated in an autocrine manner, which activates AKT signaling and its downstream hairy and enhancer of split‐1 (HES1), thereby promoting tumor cell proliferation.224. Here, FGFR2 is linked to endometrial cancer.